Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Combination of traditional Chinese medicine and epidermal growth factor receptor tyrosine kinase inhibitors in the treatment of non-small cell lung cancer
Xinbing Sui, Mingming Zhang, Xuemeng Han, et al.
Medicine (2020) Vol. 99, Iss. 32, pp. e20683-e20683
Open Access | Times Cited: 19

Showing 19 citing articles:

Drug tolerant persister cell plasticity in cancer: A revolutionary strategy for more effective anticancer therapies
Jun He, Zejing Qiu, Jingjing Fan, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 11
Development of modern Chinese medicine guided by molecular compatibility theory
Lifeng Luo, Jieru Zhou, Xiaonan Liu, et al.
Journal of Advanced Research (2024)
Open Access | Times Cited: 8
The role of artificial intelligence in drug screening, drug design, and clinical trials
Yaojiong Wu, Li Ma, Xinyi Li, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 4
Nootkatone inhibits the progression of glioblastoma by activating the ATF4-CHOP-CHAC1 pathway
Qian Wang, Xiumin Xue, Zhichao Chen, et al.
Molecular Medicine (2025) Vol. 31, Iss. 1
Open Access
Research progress on new physical therapies for cancer (Review)
Jing Xi, Cheng Ji, Haixin Sun, et al.
Oncology Letters (2025) Vol. 29, Iss. 6, pp. 1-14
Open Access
Structure-based design of anticancer drugs based on β-elemene: Research foundations and development potential
Haiyi Chen, Yuntao Yu, Chenghong Hu, et al.
Journal of Pharmaceutical Analysis (2025), pp. 101325-101325
Open Access
Forsythoside B suppresses glioblastoma by upregulating the expression of PTPRN
Zhichao Chen, Fei‐Fei Liu, Qian Wang, et al.
Neuropharmacology (2025), pp. 110514-110514
Closed Access
CACA guidelines for holistic integrative management of lung cancer
Jun Wang
Holistic Integrative Oncology (2024) Vol. 3, Iss. 1
Open Access | Times Cited: 3
Medicinal herbs and bioactive compounds overcome the drug resistance to epidermal growth factor receptor inhibitors in non‑small cell lung cancer (Review)
H. -S. Lee, Mingjing Meng, Yulong Liu, et al.
Oncology Letters (2021) Vol. 22, Iss. 3
Open Access | Times Cited: 17
Chinese Herbal Medicine Combined With First-Generation EGFR-TKIs in Treatment of Advanced Non-Small Cell Lung Cancer With EGFR Sensitizing Mutation: A Systematic Review and Meta-Analysis
Yan Lu, Chenbing Sun, Lijing Jiao, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 14
Revealing the active ingredients and mechanism of P. sibiricumm in non-small-cell lung cancer based on UPLC-Q-TOF-MS/MS, network pharmacology, and molecular docking
Kaili Guo, Yu Jiang, Wei Qiao, et al.
Heliyon (2024) Vol. 10, Iss. 7, pp. e29166-e29166
Open Access | Times Cited: 1
Targeting programmed cell death via active ingredients from natural plants: a promising approach to cancer therapy
Qian Li, Yan Tong, Jianxiang Chen, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 1
Kanglaite Combined With Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor Therapy for Stage III/IV Non-Small Cell Lung Cancer: A PRISMA-Compliant Meta-Analysis
Fanming Kong, Chaoran Wang, Xiaojiang Li, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 6
Shashen maidong decoction: the effect of TNF-α and IL-6 on lung cancer cachexia based on cancer toxicity theory.
Meiyan He, Ying Luo, Lujie Chen, et al.
American Journal of Translational Research (2021) Vol. 13, Iss. 6, pp. 6752-6758
Closed Access | Times Cited: 4
The mechanism of Wenhua Decoction in the treatment of non-small cell lung cancer by network pharmacology and molecular dynamics simulation
Dong-Zhi Wei
Journal of Herbal Medicine (2024) Vol. 48, pp. 100934-100934
Closed Access
The role and mechanism of “eight famous herbals in Zhejiang” in cancer via network pharmacology and experimental validation
Ziheng Ni, Hao Zhang, Fengyun Chen, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access
Integrating natural woody composites with modern therapies for enhanced lung cancer treatment
Qingyu, GuanyanLi, Yafeng Yang, et al.
Advanced Composites and Hybrid Materials (2024) Vol. 8, Iss. 1
Closed Access
Efficacy and safety of EGFR‑TKIs plus Shenqi Fuzheng injection for non-small cell lung cancer patients with EGFR-sensitive mutations
Jiali Wang, Chuan-sheng Chen, Zhirong Jia, et al.
Journal of Cancer Research and Clinical Oncology (2022) Vol. 149, Iss. 7, pp. 3895-3903
Open Access | Times Cited: 2
Editorial: Chemosensitizing effect of natural products against cancers: Applications in enhancing chemotherapy and immunotherapy
Nand Kishor Roy, Devesh Tewari, Maria Teresa Esposito
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 1
Alpha Ketoglutarate Downregulates the Neutral Endopeptidase and Enhances the Growth Inhibitory Activity of Thiorphan in Highly Aggressive Osteosarcoma Cells
Magdalena Mizerska-Kowalska, Adrianna Sławińska-Brych, Emilia Niedziela, et al.
Molecules (2022) Vol. 28, Iss. 1, pp. 97-97
Open Access | Times Cited: 1
Page 1

Scroll to top